Abstract
HPV infection of squamous epithelium of female genital. tract results in a variety of clinical. diseases. HPV types 6 and 11, are generally associated with benign proliferative lesions such as condylomata acuminata, while numerous “high risk” HPV types are involved in the development of cervical. dysplasia that can progress to malignancy. In particular HPV type 16 is one of the most important etiological. agent in cervical. squamous carcinoma. Several. studies have demonstrated that HPV16 infection can elicit a humoral. immune response. Serological. assays using different sources of HPV16 antigens, such as synthetic peptides, or protein expressed in prokaryotic or eukaryotic systems, have shown a significant correlation between the presence of antibodies to some HPV16 proteins and cervical. cancer. Antibodies against the transforming protein E6 and E7 have been detected frequently and with high seroprevalence in cervical. cancer cases1,2,3. In contrast little is known about the serological. response to the virus throughout the different stages of the infection to the development of the tumour.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M. Muller, R.P. Viscidi, Y. Sun, E. Guerrero, P.M. Hill, F. Shah, F.X. Bosch, N. Munoz, L. Gissmann and K.V. Shah, Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16 associated invasive cervical. cancer, Virol. 187:508–514 (1992).
A.K. Ghosh, N.K. Smith, S.N. Stacey, S.S.Glew, M.E. Connor, J.R. Arrand and P.L. Stern, Serological responses to HPV 16 in cervical. dysplasia and neoplasia: correlation of antibodies to E6 with cervical. cancer, Int J Cancer 53:591–596 (1993).
S.N. Stacey, J.S. Bartholomew, A. Ghosh, P.L. Stern, M. Mackett and J.R. Arrand, Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera, J Gen Virol. 73:2337–2345 (1992).
J. Dillner, L. Dillner, G. Utter, C. Eklund, A. Rotola, S. Costa and D. Di Luca, Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames, Int J Cancer 45:529–535 (1990).
N. D. Christensen, J.W. Kreider, N.M. Cladel and D.A. Galloway, Immunological. cross-reactivity to laboratory produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins, Virol. 75:1–9 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Di Lonardo, A., Campo, M.S., Marcante, M.L. (1994). Serological Response to HPV16 Infection. In: Stanley, M.A. (eds) Immunology of Human Papillomaviruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2449-6_18
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2449-6_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6041-4
Online ISBN: 978-1-4615-2449-6
eBook Packages: Springer Book Archive